Spinorphin (TFA)

• Description :

  Spinorphin TFA is an inhibitor of enkephalin-degrading enzymes. Spinorphin inhibits aminopeptidase, dipeptidyl aminopeptidase III, angiotensin-converting enzyme and enkephalinase. Spinorphin possesses an antinociceptive effect[1].

• Product Name Alternative :

  LVV-hemorphin-4 (TFA)

• UNSPSC :

  12352209

• Target :

  Angiotensin Receptor

• Type :

  Natural Products

• Related Pathways :

  GPCR/G Protein

• Applications :

  Neuroscience-Neuromodulation

• Field of Research :

  Neurological Disease

• Assay Protocol :

  https://www.medchemexpress.com/spinorphin-tfa.html

• Purity :

  99.44

• Solubility :

  H2O : 33.33 mg/mL (ultrasonic)

• Smiles :

  C[C@@H](O)[C@@H](C(O)=O)NC([C@H](CC1=CNC2=C1C=CC=C2)NC([C@H]3N(C([C@H](CC4=CC=C(O)C=C4)NC([C@H](C(C)C)NC([C@H](C(C)C)NC([C@H](CC(C)C)N)=O)=O)=O)=O)CCC3)=O)=O.OC(C(F)(F)F)=O

• Molecular Formula :

  C47H65F3N8O12

• Molecular Weight :

  991.06

• References & Citations :

  [1]M Honda, et al. Spinorphin, an endogenous inhibitor of enkephalin-degrading enzymes, potentiates leu-enkephalin-induced anti-allodynic and antinociceptive effects in mice. Jpn J Pharmacol. 2001 Dec;87 (4) :261-7.

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light, under nitrogen)

• Scientific Category :

  Natural Products

• Clinical Information :

  No Development Reported

• CAS Number :

  [2828433-21-0]